blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2793945

EP2793945 - ANTIBODIES USEFUL IN PASSIVE INFLUENZA IMMUNIZATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.06.2019
Database last updated on 06.07.2024
FormerThe patent has been granted
Status updated on  13.07.2018
FormerGrant of patent is intended
Status updated on  11.03.2018
FormerExamination is in progress
Status updated on  14.11.2016
Most recent event   Tooltip03.07.2020Lapse of the patent in a contracting state
New state(s): CY, MK		published on 05.08.2020  [2020/32]
Applicant(s)For all designated states
Trellis Bioscience, LLC
845 Oak Grove Ave, Suite 202
Menlo Park, CA 94025 / US
[2018/26]
Former [2015/18]For all designated states
Trellis Bioscience, LLC
1505-B O'Brien Dr.
Menlo Park, CA 94025 / US
Former [2014/44]For all designated states
Trellis Bioscience, LLC
2-B Corporate Drive
South San Francisco, CA 94080 / US
Inventor(s)01 / KAUVAR, Lawrence M.
1438 Green Street
7A
San Francisco, CA 94109 / US
02 / ELLSWORTH, Stote
140 Seaview Court
No 1401N
Marco Island, FL 34145 / US
03 / MCCUTCHEON, Krista, Maureen
1512 Carol Avenue
Burlingame, CA 94010 / US
04 / PARK, Minha
275 Mendocino Street
Brisbane, CA 94005 / US
05 / USINGER, William
(Deceased)
(Deceased) / US
 [2014/47]
Former [2014/44]01 / KAUVAR, Lawrence M.
1438 Green Street
7A
San Francisco, CA 94109 / US
02 / ELLSWORTH, Stote
578 Lowell Avenue
Palo Alto, CA 94301 / US
03 / MCCUTCHEON, Krista, Maureen
1512 Carol Avenue
Burlingame, CA 94010 / US
04 / PARK, Minha
275 Mendocino Street
Brisbane, CA 94005 / US
05 / USINGER, William
(Deceased)
(Deceased) / US
Representative(s)V.O.
P.O. Box 87930
2508 DH Den Haag / NL
[2018/33]
Former [2014/44]Jansen, Cornelis Marinus, et al
V.O.
Johan de Wittlaan 7
2517 JR Den Haag / NL
Application number, filing date12854682.705.12.2012
[2018/33]
WO2012US68037
Priority number, dateUS201161567046P05.12.2011         Original published format: US 201161567046 P
[2014/44]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2013086052
Date:13.06.2013
Language:EN
[2013/24]
Type: A2 Application without search report 
No.:EP2793945
Date:29.10.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 13.06.2013 takes the place of the publication of the European patent application.
[2014/44]
Type: B1 Patent specification 
No.:EP2793945
Date:15.08.2018
Language:EN
[2018/33]
Search report(s)International search report - published on:US08.08.2013
(Supplementary) European search report - dispatched on:EP07.08.2015
ClassificationIPC:A61K39/00, C07K16/10
[2015/37]
CPC:
C07K16/1018 (EP,RU,US); A61K39/42 (RU); A61P31/16 (EP);
A61K2039/505 (EP,US); A61K2039/507 (EP,US); C07K2317/21 (EP,US);
C07K2317/31 (EP,US); C07K2317/33 (EP,US); C07K2317/622 (EP,US);
C07K2317/76 (EP,US); C07K2317/92 (EP,US) (-)
Former IPC [2014/44]A61K39/42, C40B30/04, A61K38/04, C07H21/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/44]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ANTIKÖRPER ZUR PASSIVEN INFLUENZA-IMMUNISIERUNG[2014/44]
English:ANTIBODIES USEFUL IN PASSIVE INFLUENZA IMMUNIZATION[2014/44]
French:ANTICORPS UTILES DANS L'IMMUNISATION PASSIVE CONTRE LA GRIPPE[2014/44]
Entry into regional phase03.07.2014National basic fee paid 
03.07.2014Search fee paid 
03.07.2014Designation fee(s) paid 
03.07.2014Examination fee paid 
Examination procedure03.07.2014Examination requested  [2014/44]
26.02.2016Amendment by applicant (claims and/or description)
14.07.2016Despatch of a communication from the examining division (Time limit: M06)
23.01.2017Reply to a communication from the examining division
30.01.2018Cancellation of oral proceeding that was planned for 05.02.2018
05.02.2018Date of oral proceedings (cancelled)
12.03.2018Communication of intention to grant the patent
09.07.2018Fee for grant paid
09.07.2018Fee for publishing/printing paid
09.07.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.07.2016
Opposition(s)16.05.2019No opposition filed within time limit [2019/30]
Fees paidRenewal fee
11.12.2014Renewal fee patent year 03
10.12.2015Renewal fee patent year 04
13.12.2016Renewal fee patent year 05
12.12.2017Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.12.2012
AL15.08.2018
CY15.08.2018
CZ15.08.2018
EE15.08.2018
FI15.08.2018
HR15.08.2018
LT15.08.2018
LV15.08.2018
MC15.08.2018
MK15.08.2018
PL15.08.2018
PT15.08.2018
RO15.08.2018
RS15.08.2018
SI15.08.2018
SK15.08.2018
SM15.08.2018
TR15.08.2018
BG15.11.2018
NO15.11.2018
GR16.11.2018
IE05.12.2018
LU05.12.2018
MT05.12.2018
IS15.12.2018
[2020/31]
Former [2020/30]HU05.12.2012
AL15.08.2018
CZ15.08.2018
EE15.08.2018
FI15.08.2018
HR15.08.2018
LT15.08.2018
LV15.08.2018
MC15.08.2018
PL15.08.2018
PT15.08.2018
RO15.08.2018
RS15.08.2018
SI15.08.2018
SK15.08.2018
SM15.08.2018
TR15.08.2018
BG15.11.2018
NO15.11.2018
GR16.11.2018
IE05.12.2018
LU05.12.2018
MT05.12.2018
IS15.12.2018
Former [2020/28]AL15.08.2018
CZ15.08.2018
EE15.08.2018
FI15.08.2018
HR15.08.2018
LT15.08.2018
LV15.08.2018
MC15.08.2018
PL15.08.2018
PT15.08.2018
RO15.08.2018
RS15.08.2018
SI15.08.2018
SK15.08.2018
SM15.08.2018
TR15.08.2018
BG15.11.2018
NO15.11.2018
GR16.11.2018
IE05.12.2018
LU05.12.2018
MT05.12.2018
IS15.12.2018
Former [2020/16]AL15.08.2018
CZ15.08.2018
EE15.08.2018
FI15.08.2018
HR15.08.2018
LT15.08.2018
LV15.08.2018
MC15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SI15.08.2018
SK15.08.2018
SM15.08.2018
TR15.08.2018
BG15.11.2018
NO15.11.2018
GR16.11.2018
IE05.12.2018
LU05.12.2018
MT05.12.2018
IS15.12.2018
Former [2020/08]AL15.08.2018
CZ15.08.2018
EE15.08.2018
FI15.08.2018
HR15.08.2018
LT15.08.2018
LV15.08.2018
MC15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SI15.08.2018
SK15.08.2018
SM15.08.2018
BG15.11.2018
NO15.11.2018
GR16.11.2018
IE05.12.2018
LU05.12.2018
MT05.12.2018
IS15.12.2018
Former [2019/48]AL15.08.2018
CZ15.08.2018
EE15.08.2018
FI15.08.2018
HR15.08.2018
LT15.08.2018
LV15.08.2018
MC15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SI15.08.2018
SK15.08.2018
SM15.08.2018
BG15.11.2018
NO15.11.2018
GR16.11.2018
IE05.12.2018
LU05.12.2018
IS15.12.2018
Former [2019/40]AL15.08.2018
CZ15.08.2018
EE15.08.2018
FI15.08.2018
HR15.08.2018
LT15.08.2018
LV15.08.2018
MC15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SI15.08.2018
SK15.08.2018
SM15.08.2018
BG15.11.2018
NO15.11.2018
GR16.11.2018
LU05.12.2018
IS15.12.2018
Former [2019/39]AL15.08.2018
CZ15.08.2018
EE15.08.2018
FI15.08.2018
HR15.08.2018
LT15.08.2018
LV15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SI15.08.2018
SK15.08.2018
SM15.08.2018
BG15.11.2018
NO15.11.2018
GR16.11.2018
LU05.12.2018
IS15.12.2018
Former [2019/37]AL15.08.2018
CZ15.08.2018
EE15.08.2018
FI15.08.2018
HR15.08.2018
LT15.08.2018
LV15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SI15.08.2018
SK15.08.2018
SM15.08.2018
BG15.11.2018
NO15.11.2018
GR16.11.2018
IS15.12.2018
Former [2019/26]AL15.08.2018
CZ15.08.2018
EE15.08.2018
FI15.08.2018
HR15.08.2018
LT15.08.2018
LV15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SK15.08.2018
SM15.08.2018
BG15.11.2018
NO15.11.2018
GR16.11.2018
IS15.12.2018
Former [2019/24]AL15.08.2018
CZ15.08.2018
EE15.08.2018
FI15.08.2018
HR15.08.2018
LT15.08.2018
LV15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SK15.08.2018
BG15.11.2018
NO15.11.2018
GR16.11.2018
IS15.12.2018
Former [2019/22]AL15.08.2018
CZ15.08.2018
FI15.08.2018
HR15.08.2018
LT15.08.2018
LV15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
BG15.11.2018
NO15.11.2018
GR16.11.2018
IS15.12.2018
Former [2019/12]AL15.08.2018
FI15.08.2018
HR15.08.2018
LT15.08.2018
LV15.08.2018
RS15.08.2018
BG15.11.2018
NO15.11.2018
GR16.11.2018
IS15.12.2018
Former [2019/11]FI15.08.2018
HR15.08.2018
LT15.08.2018
RS15.08.2018
BG15.11.2018
NO15.11.2018
GR16.11.2018
IS15.12.2018
Former [2019/08]FI15.08.2018
LT15.08.2018
NO15.11.2018
IS15.12.2018
Former [2019/07]LT15.08.2018
Documents cited:Search[XI]WO2010130636  (CRUCELL HOLLAND BV [NL], et al);
International search[Y]US4625015  (GREEN NICOLA [US], et al);
 [A]US2009203538  (SUGIOKA ATSUSHI [JP], et al);
 [A]US2009311183  (DEVY LAETITIA [US], et al);
 [A]WO2010027818  (DANA FARBER CANCER INST INC [US], et al);
 [Y]US2010086555  (LANZAVECCHIA ANTONIO [CH]);
 [A]WO2011126370  (UNIV UTRECHT HOLDING BV [NL], et al);
 [AP]WO2011160083  (TRELLIS BIOSCIENCE INC [US], et al);
by applicantWO2004080403
 US7413868
 WO2011160083
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.